Evidence map›Paper›PMID 38081600›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[

Y Wu, Q Zuo, W Luo, H Wang, D Pi, Q Chen, L Chen, L Lin, M Ouyang

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Y WuSecond Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Q ZuoState Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
W LuoSecond Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
H WangCollege of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
D PiCollege of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
Q ChenState Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
L ChenCollege of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
L LinOncology Center, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
M OuyangCollege of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effects of

methodsSixteen female ICR mice bearing intraperitoneal Lewis lung adenocarcinoma xenografts were randomized into model group and YFSJ treatment group (daily dose of 4 g/kg for 21 days,

resultsTreatment with YFSJ significantly increased skeletal muscle strength and gastrocnemius muscle weight (

conclusionYFSJ alleviates cancer-related skeletal muscle atrophy possibly by reducing inflammatory insulin resistance.

Indexed as

Insulin ResistanceNeoplasmsAnimalsCytokinesFemaleGlycogenHumansLipidsMiceMice, Inbred ICRMuscle, SkeletalMuscular AtrophyProto-Oncogene Proteins c-aktCytokinesGlycogenLipidsProto-Oncogene Proteins c-aktcancer-related skeletal muscle atrophyinflammatory insulin resistanceYifei Sanjie Pills

Identifiers

PMID38081600
PMCPMC10713459
OpenAlexW4389803075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.